CLINICAL_TRIALS
trial_result
· 2023-03-03
Clinical Trial Update: DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder [Phase 4]
Summary
A Phase 4 clinical trial on carbamazepine (Equetro) for maintenance in children with acute manic or mixed bipolar disorder has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Validus Pharmaceuticals | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED